Most Recent
Hiding name of buyer in Antares oil deal a breach of disclosure obligations, court says
In a win for ASIC, a judge has found that former oil and gas company Antares Energy violated its continuous disclosure obligations by failing to reveal the name of the buyer behind an ill-fated US$254 million acquisition of Texan oil assets.
ATO wins appeal in $60M tax dispute with Healius
The Australian Taxation Office has secured a Full Federal Court victory in its $60 million tax battle with Healius, overturning a ruling that found the healthcare company could claw back a multi-million dollar tax refund.
VW escapes ASIC responsible lending case with $4.7M remediation promise
The Australian Securities and Investments Commission has settled its responsible lending case against Volkswagen's financial services unit with an undertaking from the car financier to repay customers $4.7 million.
Noni B owner fights ACMA bid for docs over potential Spam Act violations
Mosaic Brands has taken the Australian Communications and Media Authority to court, alleging a request for documents based on suspected Spam Act violations is invalid.
Delegate deflates Ann Taylor’s opposition to Nike’s ‘Aeroloft’ trade mark
US women's clothing retailer Ann Taylor has come up short in its opposition to Nike's bid to register the 'Aeoroloft' mark for its brand of lightweight fitness apparel, with an IP Australia finding the mark is not deceptively similar to Ann Taylor's 'Loft' mark.
Zip Co crushes Flexigroup’s ‘No Interest’ trade mark
Fintech Zip Co has successfully opposed rival Flexigroup's attempt to trade mark 'No Interest Ever!', in the latest trade mark battle between buy now, pay later service providers in Australia.
Full Court gives Branhaven another shot at bovine gene patent
Australia's leading livestock group cannot block US company Branhaven from amending its application for a bovine genome patent, which the group has worried could harm the Australian cattle industry's ability to use genetic tests.
Merck Sharp & Dohme drops lawsuit over Januvia patent
Merck Sharp & Dohme has dropped a lawsuit brought against a unit of Indian generic manufacturer Lupin for allegedly threatening to infringe the patent for its multibillion-dollar diabetes drugs Januvia and Janumet.
Class members would get ‘diddly-squat’ in $1.9M Appco settlement, judge says
A judge has said further investigation into the financial position of Appco Group is needed before he can sign off on a $1.9M settlement in a $65 million sham contracting class action against the fundraising company, under which litigation funder Harbour would get a 50 per cent cut and group members would recover “diddly-squat”.
High Court won’t hear Rokt appeal on software patentability
The High Court has declined to weigh in on the patentability of software, rejecting e-commerce company Rokt's bid for review of a decision striking down its marketing invention.